About Anne Whitaker
Anne Whitaker is a director at Bryn Pharma.
Form D filings also name Anne Whitaker as a chief executive officer, chairwoman of the board at Aerami Therapeutics Holdings.
Anne Whitaker first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Anne Whitaker in the role, so the role may have started earlier or lasted longer.
Aerami Therapeutics Holdings, Inc.
Chief Executive Officer, Chairwoman of the Board
2019 – 2023 · Durham, NC
Key Colleagues at Startups
The people Anne Whitaker works with at each company, as listed on that company's latest Form D.
Bryn Pharma, Inc. · Form D, Aug 14, 2025
MK
Michael Kaseta
Director
JH
Jeff Hartness
Director
SH
Steven Hartman
Director
JZ
Joshua Ziel
Executive officer
ML
Michelle Lobel
Director
SK
MR
Marc Rapaport
Director
LL
Lisa Licht
Director
SL
Sandra Loreaux
Director
JB
James Borneman
Executive officer
KD
Kate Soper Diaz
Director
Aerami Therapeutics Holdings, Inc. · Form D, Nov 22, 2023
GB
Gary Burgess
Chief Medical Officer
AS
Adam Stern
Director
JP
John Patton
Director
ST
Steven Thornton
Director
WW
William Welch
Director
JZ
Joshua Ziel
Chief Operating Officer
DH
Darlene Deptula-Hicks
Chief Financial Officer and Director